propranolol has been researched along with Pulmonary Hypertension in 28 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We determined whether milrinone, a phosphodiesterase III inhibitor, attenuates serotonin-induced (5-hydroxytryptamine [5HT]) pulmonary hypertension (PH) and bronchoconstriction." | 7.70 | Milrinone attenuates serotonin-induced pulmonary hypertension and bronchoconstriction in dogs. ( Hashiba, E; Hashimoto, Y; Hirota, K; Kudo, T; Matsuki, A; Sato, T; Yoshioka, H, 2000) |
| "In the present study in dogs, we compared with aminophylline the spasmolytic effects of olprinone, a novel phosphodiesterase 3 inhibitor, on serotonin-induced pulmonary hypertension (PH) and bronchoconstriction." | 7.70 | A comparison of the spasmolytic effects of olprinone and aminophylline on serotonin-induced pulmonary hypertension and bronchoconstriction with or without beta-blockade in dogs. ( Hashimoto, Y; Hirota, K; Ishihara, H; Kudo, T; Matsuki, A; Yoshioka, H, 2000) |
| "Thirteen patients with severe hypertension were treated with combined minoxidil, propranolol, and furosemide (mean daily doses 33 mg, 475 mg, and 578 mg, respectively) for nine to twenty-five months (mean 13." | 7.65 | Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide. ( Bennet, CM; Blaufuss, A; Wilburn, RL, 1975) |
| "Detailed examination of hemodynamics in patients with portal and pulmonary hypertension was performed upon acute drug tests and course administration of nitrosorbide++, corinfar and propranolol." | 5.07 | [Drug therapy of pulmonary and portal hypertension in liver cirrhosis]. ( Andreev, NG; Maev, IV; Vorob'ev, LP, 1991) |
| "The study consisted of six groups (N=30; five rabbits/group): (1) Control with no pretreatment, monocrotaline injected groups: (solutions were perfused following termination of CPB for 60 min); (2) Control for pulmonary hypertension (PHT); (3) isoproteronol; (4) VIP 10(-6) M; (5) VIP 10(-5) M; (6) nitroglycerine." | 3.71 | The effects of vasoactive intestinal peptide on monocrotaline induced pulmonary hypertensive rabbits following cardiopulmonary bypass: a comparative study with isoproteronol and nitroglycerine. ( Chang, D; Gunaydin, S; Hagino, I; Imai, Y; Seo, K; Shinoka, T; Takanashi, Y, 2002) |
| "We determined whether milrinone, a phosphodiesterase III inhibitor, attenuates serotonin-induced (5-hydroxytryptamine [5HT]) pulmonary hypertension (PH) and bronchoconstriction." | 3.70 | Milrinone attenuates serotonin-induced pulmonary hypertension and bronchoconstriction in dogs. ( Hashiba, E; Hashimoto, Y; Hirota, K; Kudo, T; Matsuki, A; Sato, T; Yoshioka, H, 2000) |
| "In the present study in dogs, we compared with aminophylline the spasmolytic effects of olprinone, a novel phosphodiesterase 3 inhibitor, on serotonin-induced pulmonary hypertension (PH) and bronchoconstriction." | 3.70 | A comparison of the spasmolytic effects of olprinone and aminophylline on serotonin-induced pulmonary hypertension and bronchoconstriction with or without beta-blockade in dogs. ( Hashimoto, Y; Hirota, K; Ishihara, H; Kudo, T; Matsuki, A; Yoshioka, H, 2000) |
| "Hypoxia causes the release of atrial natriuretic factor (ANF), but the mechanisms are not yet understood." | 3.68 | Neural control of ANF release in hypoxia and pulmonary hypertension. ( Baertschi, AJ; Campbell, RW; Carlson, DE; Gann, DS; Jiao, JH; Teague, WG; Willson, D, 1990) |
| "Thirteen patients with severe hypertension were treated with combined minoxidil, propranolol, and furosemide (mean daily doses 33 mg, 475 mg, and 578 mg, respectively) for nine to twenty-five months (mean 13." | 3.65 | Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide. ( Bennet, CM; Blaufuss, A; Wilburn, RL, 1975) |
| "Pretreatment with methysergide, a serotonin antagonist, partially attenuated the effects of CuSO4." | 1.26 | Acute pulmonary hemodynamic effects of intravenous copper sulfate: role of alpha-adrenergic system. ( Ahmed, T; Eyre, P; Januszkiewicz, A; Robinson, MJ; Sackner, MA, 1981) |
| "4 sec; long-term administration av." | 1.26 | Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension. ( Hashimoto, M; Miyamoto, K; Otsuka, K; Tsukiyama, H; Yasutake, S, 1976) |
| "We advocate the use of propranolol in very low dosage at the end of operation to determine a prognosis of the long-term results to be expected after valvulotomy in diverse types of pulmonary stenosis." | 1.26 | The postvalvulotomy propranolol test to determine reversibility of the residual gradient in pulmonary stenosis. ( Buis-Liem, TN; Geldof, WC; Moulaert, AJ; Rohmer, J, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (46.43) | 18.7374 |
| 1990's | 5 (17.86) | 18.2507 |
| 2000's | 7 (25.00) | 29.6817 |
| 2010's | 3 (10.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, YM | 1 |
| Cheng, CC | 1 |
| Wann, SR | 1 |
| Lin, SL | 1 |
| Diong, C | 1 |
| Jones, PP | 1 |
| Tsuchimochi, H | 2 |
| Gray, EA | 1 |
| Hughes, G | 1 |
| Inagaki, T | 1 |
| Bussey, CT | 1 |
| Fujii, Y | 1 |
| Umetani, K | 2 |
| Shirai, M | 2 |
| Schwenke, DO | 2 |
| Pearson, JT | 1 |
| Shimochi, A | 1 |
| Kangawa, K | 1 |
| Cragg, PA | 1 |
| Kamalanathan, S | 1 |
| Balachandran, K | 1 |
| Packirisamy, G | 1 |
| Hamide, A | 1 |
| Brimioulle, S | 1 |
| Wauthy, P | 1 |
| Ewalenko, P | 1 |
| Rondelet, B | 1 |
| Vermeulen, F | 1 |
| Kerbaul, F | 1 |
| Naeije, R | 1 |
| TSOLAKAS, TC | 1 |
| DAVIES, JP | 1 |
| ORAM, S | 1 |
| Okada, Y | 1 |
| Hoshikawa, Y | 1 |
| Ejima, Y | 1 |
| Matsumura, Y | 1 |
| Sado, T | 1 |
| Shimada, K | 1 |
| Aikawa, H | 1 |
| Sugawara, T | 1 |
| Matsuda, Y | 1 |
| Takahashi, T | 1 |
| Sato, M | 1 |
| Kondo, T | 1 |
| Wasseem, R | 1 |
| Mazen, E | 1 |
| Walid, SR | 1 |
| Ahmed, T | 1 |
| Januszkiewicz, A | 1 |
| Eyre, P | 1 |
| Robinson, MJ | 1 |
| Sackner, MA | 1 |
| Galinier, M | 1 |
| Rougé, P | 1 |
| Fourcade, J | 1 |
| Senard, JM | 1 |
| Albenque, JP | 1 |
| Balanescu, S | 1 |
| Doazan, JP | 1 |
| Montastruc, JL | 1 |
| Bounhoure, JP | 1 |
| Montastruc, P | 1 |
| Buchhorn, R | 1 |
| Hulpke-Wette, M | 1 |
| Wessel, A | 1 |
| Bürsch, J | 1 |
| Hashiba, E | 1 |
| Hirota, K | 2 |
| Yoshioka, H | 2 |
| Hashimoto, Y | 2 |
| Kudo, T | 2 |
| Sato, T | 1 |
| Matsuki, A | 2 |
| Ishihara, H | 1 |
| Gunaydin, S | 1 |
| Imai, Y | 1 |
| Takanashi, Y | 1 |
| Seo, K | 1 |
| Hagino, I | 1 |
| Chang, D | 1 |
| Shinoka, T | 1 |
| Tsukiyama, H | 1 |
| Otsuka, K | 1 |
| Miyamoto, K | 1 |
| Hashimoto, M | 1 |
| Yasutake, S | 1 |
| Moulaert, AJ | 1 |
| Buis-Liem, TN | 1 |
| Geldof, WC | 1 |
| Rohmer, J | 1 |
| Moret, PR | 1 |
| Duchosal, F | 1 |
| von Wichert, P | 1 |
| Khamzamulin, RO | 1 |
| Mirrakhimov, MM | 1 |
| Brimkulov, NN | 1 |
| Kaliuzhnyĭ, SI | 1 |
| Wilburn, RL | 1 |
| Blaufuss, A | 1 |
| Bennet, CM | 1 |
| Maev, IV | 3 |
| Vorob'ev, LP | 3 |
| Kaziulin, AN | 1 |
| Andreev, NG | 1 |
| Baertschi, AJ | 1 |
| Jiao, JH | 1 |
| Carlson, DE | 1 |
| Campbell, RW | 1 |
| Teague, WG | 1 |
| Willson, D | 1 |
| Gann, DS | 1 |
| Sun, RY | 1 |
| Völkel, N | 1 |
| Siemssen, S | 1 |
| Kaukel, E | 1 |
| Sill, V | 1 |
| Vogel, JH | 1 |
| Chidsey, CA | 1 |
| Mielke, H | 1 |
| Seiler, KU | 1 |
| Stumpf, U | 1 |
| Wassermann, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Untersuchung Des Einflusses PAH-spezifischer Medikation Auf Die rechtsventrikuläre Funktion Bei Patienten Mit Pulmonaler Arterieller Hypertonie (PAH) Unter Basalen Bedingungen[NCT03362047] | Phase 2 | 30 participants (Anticipated) | Interventional | 2018-03-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for propranolol and Pulmonary Hypertension
| Article | Year |
|---|---|
[Drug therapy of pulmonary and portal hypertension in liver cirrhosis].
Topics: Adult; Aged; Antihypertensive Agents; Humans; Hypertension, Portal; Hypertension, Pulmonary; Isosorb | 1991 |
27 other studies available for propranolol and Pulmonary Hypertension
| Article | Year |
|---|---|
Ankylosing spondylitis associated with pulmonary arterial hypertension.
Topics: Adult; Antihypertensive Agents; Heart Atria; Humans; Hypertension, Pulmonary; Male; Propranolol; Spo | 2015 |
Sympathetic hyper-excitation in obesity and pulmonary hypertension: physiological relevance to the 'obesity paradox'.
Topics: Adrenergic beta-Antagonists; Animals; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Lung | 2016 |
Changes in pulmonary blood flow distribution in monocrotaline compared with hypoxia-induced models of pulmonary hypertension: assessed using synchrotron radiation.
Topics: Adrenergic beta-Antagonists; Angiography; Animals; Disease Models, Animal; Hypertension, Pulmonary; | 2009 |
Graves' disease--familiar foe, unfamiliar face.
Topics: Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Antithyroid Agents; Atrial Fibrillation; Car | 2012 |
Single-beat estimation of right ventricular end-systolic pressure-volume relationship.
Topics: Animals; Cardiotonic Agents; Dobutamine; Dogs; Hypertension, Pulmonary; Myocardial Contraction; Pred | 2003 |
EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT ON THELATION IN MITRAL STENOSIS.
Topics: Adrenergic Antagonists; Adrenergic beta-Antagonists; Cardiac Catheterization; Cardiac Output; Heart | 1965 |
Beta-blocker prevented repeated pulmonary hypertension episodes after bilateral lung transplantation in a patient with primary pulmonary hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Transplantat | 2004 |
Hyperthyroidism: a rare cause of reversible pulmonary hypertension.
Topics: Antihypertensive Agents; Antithyroid Agents; Female; Humans; Hypertension, Pulmonary; Hyperthyroidis | 2006 |
Acute pulmonary hemodynamic effects of intravenous copper sulfate: role of alpha-adrenergic system.
Topics: Animals; Chlorpheniramine; Copper; Copper Sulfate; Female; Hydroxydopamines; Hypertension, Pulmonary | 1981 |
Lack of haemodynamic effects of nitric oxide on post-capillary pulmonary hypertension induced by acute sino-aortic denervation.
Topics: Adrenergic beta-Antagonists; Animals; Denervation; Dogs; Enzyme Inhibitors; Hemodynamics; Hypertensi | 1997 |
Beta-blocker therapy in an infant with pulmonary hypertension.
Topics: Adrenergic beta-Antagonists; Humans; Hypertension, Pulmonary; Infant; Norepinephrine; Propranolol | 1999 |
Milrinone attenuates serotonin-induced pulmonary hypertension and bronchoconstriction in dogs.
Topics: Animals; Bronchoconstriction; Catecholamines; Dogs; Hypertension, Pulmonary; Milrinone; Phosphodiest | 2000 |
A comparison of the spasmolytic effects of olprinone and aminophylline on serotonin-induced pulmonary hypertension and bronchoconstriction with or without beta-blockade in dogs.
Topics: Adrenergic beta-Antagonists; Aminophylline; Animals; Bronchoconstriction; Bronchodilator Agents; Dog | 2000 |
The effects of vasoactive intestinal peptide on monocrotaline induced pulmonary hypertensive rabbits following cardiopulmonary bypass: a comparative study with isoproteronol and nitroglycerine.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Calcium Channel Blockers; Cardiopulm | 2002 |
Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Circulation; Blood Pressure; Cardiac Output; Female; | 1976 |
The postvalvulotomy propranolol test to determine reversibility of the residual gradient in pulmonary stenosis.
Topics: Cardiac Catheterization; Cardiomegaly; Child; Child, Preschool; Electrocardiography; Humans; Hyperte | 1976 |
[Effects of propranolol on pulmonary hypertension, right ventricular hypertrophy and metabolic myocardial changes due to acute hypoxemia due to high altitude].
Topics: Altitude; Animals; Cardiomegaly; Energy Metabolism; Hypertension, Pulmonary; Male; Myocardium; Propr | 1976 |
[Drug side-effects in the lung].
Topics: Antineoplastic Agents; Asthma; Carbamazepine; Cromolyn Sodium; Drug-Related Side Effects and Adverse | 1978 |
[Effect of obsidan on the cardiovascular system under conditions of high-altitude hypoxia].
Topics: Adaptation, Physiological; Adult; Altitude; Blood Pressure; Cerebrovascular Circulation; Hemodynamic | 1978 |
Long-term treatment of severe hypertension with minoxidil, propranolol and furosemide.
Topics: Cardiac Catheterization; Drug Therapy, Combination; Echocardiography; Edema; Furosemide; Humans; Hyd | 1975 |
[Pulmonary hemodynamics in patients with hypertension during acute drug tests using obsidan and corinfar].
Topics: Adult; Female; Hemodynamics; Humans; Hypertension; Hypertension, Pulmonary; Male; Middle Aged; Nifed | 1991 |
Neural control of ANF release in hypoxia and pulmonary hypertension.
Topics: Animals; Atrial Natriuretic Factor; Female; Hypertension, Pulmonary; Hypoxia; Male; Nervous System; | 1990 |
[Use of beta blockaders in pulmonary hypertension in patients with liver diseases].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Drug Evaluation; Hepatitis, Chronic; Humans; H | 1989 |
[Effect of propranolol on attenuation of rat hypoxic pulmonary hypertension due to radix angelicae sinensis].
Topics: Animals; Drugs, Chinese Herbal; Hypertension, Pulmonary; Hypoxia; Male; Propranolol; Rats; Rats, Inb | 1988 |
[Significance of the beta-receptor system for the Euler-Liljestrand mechanism].
Topics: Adrenergic beta-Antagonists; Aminophylline; Animals; Calcium; Cyclic AMP; Hypertension, Pulmonary; H | 1974 |
Cardiac adrenergic activity in experimental heart failure assessed with beta receptor blockade.
Topics: Animals; Blood Pressure; Carbon Dioxide; Cardiac Output; Cardiomegaly; Cattle; Epinephrine; Heart; H | 1969 |
[Relation between serotonin metabolism and pulmonary hypertension in rats following administration of various anorectic drugs].
Topics: Amines; Amphetamine; Animals; Appetite Depressants; Chlorphentermine; Hypertension, Pulmonary; Male; | 1973 |